INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 24, 2014 |
SVP Administration & Asst Secr
Trans History: 645
|
SVP Administration & Asst Secr | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 18,079 |
| Dec 13, 2013 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 20,000 |
| May 20, 2013 |
SVP Finance and Admin CFO and
Trans History: 645
|
SVP Finance and Admin CFO and | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $16.80 | 126,727 |
| May 20, 2013 |
SVP Finance and Admin CFO and
Trans History: 645
|
SVP Finance and Admin CFO and | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $16.80 | 135,803 |
| May 20, 2013 |
SVP Finance and Admin CFO and
Trans History: 645
|
SVP Finance and Admin CFO and | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 20,000 |
| May 20, 2013 |
SVP Finance and Admin CFO and
Trans History: 645
|
SVP Finance and Admin CFO and | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | -- |
| Nov 21, 2012 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $16.80 | 29,372 |
| Nov 21, 2012 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 16,923 |
| Feb 21, 2012 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $20.32 | 58,337 |
| Feb 21, 2012 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.